Headlands Research

Home
United States
Lake Worth, FL
Headlands Research

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Headlands Research, Healthcare administrator, Lake Worth, FL.

01/29/2026

We are pleased to highlight Dr. Mark A. Goldstein, Founder, former President and Medical Director, and current Principal Investigator and Senior Advisor, Neuroscience at JEM Research Institute, a Headlands Research site.

Dr. Goldstein began working in clinical research in the late 1990s and has since participated in more than 175 clinical trials, serving as Principal Investigator in over 125 of them. As a founding member and CEO of JEM Research Institute, he has guided the site’s growth into a leading center for clinical trials, with a focus on progressive cognitive decline and other neurological conditions.

He is a Certified Principal Investigator (CPI), board-certified in both internal medicine and neurology, and is currently a Fellow of the Academy of Physicians in Clinical Research (FAPCR), as well as a Fellow of the American Academy of Neurology (FAAN). He has held several leadership roles in health systems across Palm Beach County.

01/27/2026

We’re looking forward to attending SCOPE and connecting with others who are advancing clinical research! Through our global network of sites, experienced investigators, and diverse patient populations, we work every day to make clinical research more accessible to all.

Reach out to a Headlands Research team member to schedule a meeting and learn how we can support your upcoming research:

• Lauren Chazal, Chief Business Development Officer
• McKenzie Lang, Director of Business Development
• Ken Northrop, Site Director at Headlands Research Orlando

https://headlandsresearch.com/events/scope-2026/

01/23/2026

We’re pleased to highlight Dr. Eric Chavez, Principal Investigator at the Artemis Institute for Clinical Research, part of the Headlands Research network of sites.

Dr. Chavez completed his undergraduate degree at Harvard University and earned his medical degree from the Uniformed Services University of the Health Sciences. After serving in the US Navy, he went on to complete his psychiatry residency at UC San Diego and later earned a Master of Science in Medical Informatics from Northwestern University.

Since joining Artemis in 2014, Dr. Chavez has led and supported clinical trials across a wide range of therapeutic areas, including addiction disorders, depression, bipolar disorder, anxiety, schizophrenia, and attention deficit disorder. His work combines deep clinical expertise with a strong foundation in medical informatics, allowing him to bring a data-driven, patient-centered approach to psychiatric research.

We’re proud to have Dr. Chavez’s leadership and commitment to advancing mental health research within the Headlands Research network.

01/21/2026

Headlands Research is heading to SCOPE this February!

As a multinational, integrated clinical trial site organization, we’re proud to be part of the conversations shaping the future of clinical research. With experience supporting over 5,000 clinical trials, our focus remains the same: delivering meaningful participant experiences and the highest quality data.

If you’ll be at SCOPE, we’d love to connect. Reach out to a team member to schedule a time to chat at the event:

• Kyle Burtnett, Chief Executive Officer
• Lauren Chazal, Chief Business Development Officer
• McKenzie Lang, Director of Business Development
• Ken Northrop, Site Director at Headlands Research Orlando

https://headlandsresearch.com/events/scope-2026/

01/19/2026

As we honor Dr. Martin Luther King Jr., we recommit to building stronger, healthier communities.

At Headlands Research, we believe everyone deserves the opportunity to participate in, and benefit from, clinical research. Today reminds us to continue this work with empathy, respect, and purpose.

01/16/2026

We’re honored to see our team at Summit Research featured on Good Day Oregon (KPTV) for an important conversation on cognitive health.

In this segment, Dr. Scott Losk, Principal Investigator at Summit, breaks down:

• The difference between normal cognitive aging and dementia
• How Alzheimer’s disease fits within the broader definition of dementia
• New advances in blood-based testing that may identify Alzheimer’s earlier than ever before
• Promising progress in treatments that target the underlying biology of the disease

These innovations represent meaningful steps forward for patients, families, and caregivers, and reinforce the critical role clinical research plays in advancing care.

For information on no-cost memory screenings in the Portland area, visit summitresearchnetwork.com, or call the office at 503-228-2273

01/13/2026

We’re pleased to highlight Dr. Scott Losk, Principal Investigator at Summit Research, part of the Headlands Research network.

Dr. Losk has served as Principal Investigator for 90 clinical trials focused on Alzheimer’s disease and other dementias, contributing to research on every FDA-approved Alzheimer’s therapy currently available. He has also been a sub-investigator in more than 125 trials across a wide range of central nervous system conditions, including depression, anxiety disorders, ADHD, bipolar disorder, schizophrenia, migraine, and fibromyalgia.

Deeply involved in the Alzheimer’s community, Dr. Losk regularly provides education and presentations to caregivers, clinicians, and community groups. His extensive expertise and long-standing industry relationships give him unique access to the latest research opportunities in cognitive disorders.

We are proud to have Dr. Losk’s leadership and decades of insight driving progress in neuroscience research across the Headlands Research network.

01/07/2026

Alzheimer’s disease and other dementias remain one of the most complex challenges in medicine, but meaningful progress is underway.

In our latest blog post, Dr. Scott Losk, Principal Investigator at Summit Research, explores how clinical research in dementias is evolving. From blood-based biomarkers and earlier diagnosis to innovative therapies and more accessible drug delivery, the field is shifting toward proactive, biologically driven care focused on preserving quality of life.

Read the full blog to learn more: https://headlandsresearch.com/blogs/clinical-research-in-dementias-progress-challenges-and-future-directions/

01/06/2026

We’re proud to highlight Lawrence Sher, MD, FAAP, Associate Medical Director at Peninsula Research Associates, for his role as a co-author on a study evaluating the BNT162b2 (Pfizer–BioNTech) COVID-19 vaccine in children six months to four years of age.

Results from the program, published in the New England Journal of Medicine, show that a three-dose, 3-µg primary series was safe, immunogenic, and demonstrated 73% efficacy against symptomatic COVID-19 in young children.

Dr. Sher’s involvement reflects our ongoing commitment to advancing rigorous pediatric vaccine research that informs global public health.

Read more: https://headlandsresearch.com/news/evaluation-of-bnt162b2-covid-19-vaccine-in-children-younger-than-5-years-of-age/

01/01/2026

Wishing everyone a healthy and inspiring start to 2026!

Thank you to our participants, partners, and site teams for their commitment to advancing clinical research. We’re excited for what's ahead.

12/25/2025

In 2025, the Headlands Research network grew, our sites expanded their impact, and thousands of participants contributed to groundbreaking clinical research. Thank you to our teams, our partners, and every patient who made this progress possible. Here’s a look back at what we achieved together.

12/19/2025

We're highlighting Dr. Kinan Hreib, Medical Director and Principal Investigator at Headlands Research Eastern Massachusetts (EMA).

Dr. Hreib holds an MD, MBA, and PhD from Boston University and completed his medical and neurology training at Boston University Medical Center and Boston City Hospital. His career spans decades of clinical leadership and neurological expertise, beginning with more than 20 years as Director of Vascular Neurology at Lahey Clinic.

He later served as Chief of Neurology at Mount Auburn Hospital and then as Chief Medical Officer for Baystate Health North, where he continued practicing neurology while overseeing clinical operations.

Driven by a deep commitment to patients affected by neurodegenerative diseases, Dr. Hreib brings both compassion and scientific rigor to his work at Headlands Research EMA. His leadership is central to advancing research that supports better understanding and improved treatments for neurological conditions.

We are honored to have Dr. Hreib’s experience, vision, and dedication within the Headlands Research network.

Address

Lake Worth, FL

Website

http://www.headlandsresearch.com/

Alerts

Be the first to know and let us send you an email when Headlands Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Lake Worth?